Sfondo Header
L'angolo del dottorino
Search the site... Advanced search
✖

Symptoms of pulmonary hypertension:
what they are and when to suspect it

The most characteristic symptom of pulmonary hypertension is shortness of breath during exertion. Initially, it may occur only when climbing stairs quickly, walking uphill or engaging in more strenuous activities; as the disease progresses, it may appear during increasingly light activities. Also common are fatigue, reduced exercise tolerance, weakness, dizziness, palpitations and, in some cases, chest pain or fainting.
These symptoms are nonspecific: they can be caused by many other cardiac, respiratory, hematologic or metabolic conditions. Therefore, pulmonary hypertension cannot be recognized from a single symptom and cannot be diagnosed solely on the basis of symptoms.

Symptoms that may occur include, in particular:


The term pulmonary hypertension refers to a pathological increase in pressure within the pulmonary circulation, which may arise from very different causes. This guide focuses on symptoms and warning signs that may raise suspicion; classification, mechanisms and specific forms are covered in the specialist pages.

The most typical symptom: shortness of breath on exertion

In the early stages, a person may feel well at rest and only notice the problem during physical activity. Exertional dyspnea arises because, when oxygen demand increases, the right ventricle must pump more blood through a pulmonary circulation offering greater resistance or pressure than normal. If the cardiopulmonary system cannot increase blood flow adequately, shortness of breath and exercise limitation occur.
The change may be gradual. A person may notice having to slow down when walking with others, stopping more frequently on slopes, avoiding stairs or taking longer to complete activities that were previously easy. This slow progression can itself lead people to underestimate the symptom.

However, dyspnea is one of the most common complaints in medicine. Asthma, chronic obstructive pulmonary disease, interstitial lung disease, anemia, obesity, deconditioning, arrhythmias and many left heart disorders can produce a similar sensation. This is another reason why diagnosing pulmonary hypertension may take time: the clinical question is not simply "is there shortness of breath?" but why it has developed and whether the overall presentation suggests a disorder of the pulmonary circulation.

Fatigue, dizziness, chest pain and fainting

In particular, Fatigue is very common and may be experienced as low energy, weakness or reduced ability to sustain prolonged activity. It is not simply caused by lack of air: when cardiac output does not increase adequately during exertion, muscles and organs receive less blood flow than they require, and the person may quickly feel exhausted.
There may also be dizziness or a feeling of impending fainting, especially during exertion. The more serious manifestation is syncope, a transient loss of consciousness. In people with pulmonary hypertension, syncope during or immediately after physical activity may indicate an inability of the heart to maintain sufficient output as demand rises, and it must be carefully assessed.

Similarly, Chest pain may occur particularly in more severe forms and during exercise. However, no specific type of pain can reliably be attributed to pulmonary hypertension. New or intense pain, or pain associated with sudden shortness of breath, sweating, loss of consciousness or other signs of instability, requires urgent assessment because many other potentially serious causes exist.
In addition, palpitations are another possible symptom. They may simply reflect awareness of an increased heart rate during exertion, but in some patients they may be associated with arrhythmias. If persistent, recurrent or accompanied by dizziness or syncope, they warrant further evaluation.

When leg swelling and other signs of right heart failure develop

If elevated pulmonary pressures persist, the right ventricle may dilate and progressively lose efficiency. At this stage, signs of fluid retention may appear: swelling of the ankles and legs, rapid weight gain, a feeling of abdominal tightness or distension and, in more advanced cases, fluid accumulation in the abdomen.
Edema does not automatically mean pulmonary hypertension. It may be due to venous insufficiency, medications, kidney or liver disease, or other types of heart failure. It is more significant when it occurs with worsening dyspnea, marked fatigue, reduced walking capacity or other signs of right heart failure.

In advanced forms, dyspnea and fatigue may also occur at rest. Symptom progression is also described clinically by functional class: the less effort required to provoke shortness of breath, fatigue, chest pain or a feeling of faintness, the greater the functional limitation. There is no need to know or assign one's own functional class; it is more useful to tell the physician which specific activities have become difficult compared with before.

When symptoms should raise greater suspicion of pulmonary hypertension

Unexplained shortness of breath warrants particular attention when it persists despite assessment for more common causes or is accompanied by factors increasing the risk of certain forms of pulmonary hypertension. These include connective tissue diseases, especially systemic sclerosis, certain congenital heart diseases, portal hypertension, HIV infection, a family history of pulmonary arterial hypertension or exposure to specific medications or toxins.
Indeed, pulmonary arterial hypertension is in fact only one of the pulmonary hypertension groups. In other patients, the main cause is left heart disease, a chronic lung disease or a thromboembolic condition.

A history of pulmonary embolism also changes the clinical assessment. Most people recover without developing chronic thromboembolic pulmonary hypertension, but dyspnea or reduced exercise capacity that persists or develops after the event should be reported to a physician. Chronic thromboembolic pulmonary hypertension is a specific form requiring a dedicated diagnostic and treatment pathway.

Which symptoms require prompt assessment

Not all symptoms of pulmonary hypertension constitute an emergency, but certain signs indicate that the cardiovascular system may be struggling. Of particular importance are rapid worsening of dyspnea or activity capacity, syncope or presyncope with mild exertion, the appearance of obvious signs of right heart failure, hypotension, persistent tachycardia or poorly tolerated arrhythmias.
Sudden, severe breathlessness, acute chest pain, loss of consciousness, marked bluish discoloration or signs of shock must not be attributed independently to a previously established diagnosis: they may also indicate pulmonary embolism, acute coronary syndrome, arrhythmias or other emergencies and require urgent medical care.

When symptoms progress but are not acute, the first step is clinical assessment. Echocardiography is the first-line noninvasive test when pulmonary hypertension is suspected, but cannot by itself establish the diagnosis. Depending on the findings and clinical context, blood tests, electrocardiography, pulmonary function tests, thoracic imaging, ventilation/perfusion scintigraphy and, in appropriate cases, right heart catheterization may be needed.

Frequently asked questions about pulmonary hypertension symptoms

What is the most common symptom of pulmonary hypertension?
The most characteristic symptom is shortness of breath during physical activity, initially with greater exertion and, if the disease progresses, with increasingly light activities.

Can pulmonary hypertension cause fatigue?
Yes. Fatigue, weakness and reduced activity capacity are common because the heart may be unable to increase blood flow adequately during exertion.

Can fainting be a symptom of pulmonary hypertension?
Yes. Presyncope and syncope, particularly during or immediately after exertion, are important symptoms and require medical assessment, especially if new or recurrent.

Can swollen ankles be caused by pulmonary hypertension?
They may occur in more advanced stages, when the right ventricle struggles to pump against increased pressure in the pulmonary circulation and fluid retention develops. However, edema has many causes and is a nonspecific symptom.

Can symptoms establish a diagnosis of pulmonary hypertension?
No. Symptoms are nonspecific and may result from many cardiac, respiratory or systemic diseases. Targeted investigations and, when indicated, hemodynamic confirmation by right heart catheterization are required.

References
  1. Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Heart Journal. 2022;43(38):3618-3731. doi:10.1093/eurheartj/ehac237.
  2. Kovacs G, Bartolome S, Denton CP, et al. Definition, classification and diagnosis of pulmonary hypertension. European Respiratory Journal. 2024;64(4):2401324. doi:10.1183/13993003.01324-2024.
  3. Hoeper MM, Humbert M, Souza R, et al. A global view of pulmonary hypertension. Lancet Respiratory Medicine. 2016;4(4):306-322. doi:10.1016/S2213-2600(15)00543-3.
  4. Brown LM, Chen H, Halpern S, et al. Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry. Chest. 2011;140(1):19-26. doi:10.1378/chest.10-1166.
  5. Didden EM, Lee E, Wyckmans J, Quinn D, Perchenet L. Time to diagnosis of pulmonary hypertension and diagnostic burden: a retrospective analysis of nationwide US healthcare data. Pulmonary Circulation. 2023;13(1):e12188. doi:10.1002/pul2.12188.
  6. Armstrong I, Billings C, Kiely DG, et al. The patient experience of pulmonary hypertension: a large cross-sectional study of UK patients. BMC Pulmonary Medicine. 2019;19:67. doi:10.1186/s12890-019-0827-5.
  7. Delcroix M, Howard L. Pulmonary arterial hypertension: the burden of disease and impact on quality of life. European Respiratory Review. 2015;24(138):621-629. doi:10.1183/16000617.0063-2015.
  8. McCollister D, Shaffer S, Badesch DB, et al. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) questionnaire: a new patient-reported outcome instrument for PAH. Respiratory Research. 2016;17:72. doi:10.1186/s12931-016-0388-6.
  9. Chin KM, Gomberg-Maitland M, Channick RN, et al. Psychometric validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire: results of the SYMPHONY Trial. Chest. 2018;154(4):848-861. doi:10.1016/j.chest.2018.04.027.
  10. Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2010;137(2):376-387. doi:10.1378/chest.09-1140.

Informational notice: the information contained on this page is provided solely for informational and educational purposes and does not replace the advice, diagnosis or treatment provided by a physician. If needed, always consult a qualified healthcare professional.

Artificial intelligence transparency: this page was created with the support of artificial intelligence tools, used to assist in the production and processing of its content.